Industry Focus
Amgen Inc: Why You Shouldn't Count Chickens Before They Hatch
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:14:10
- Mais informações
Informações:
Sinopse
Amgen has shelved its once-promising psoriasis drug. Motley Fool's Michael Douglass and Todd Campbell help investors understand the impact.
